PersonAuto-indexed · Unverified
David Donabedian
Boston, US· Director, Executive Officer
Named on 7 public capital-raising filings across 5 companies. Compiled automatically from public SEC filings — not verified by this individual.
Companies
Filings (7)
Neela Therapeutics, Inc. raised $13.8M
Neela Therapeutics, Inc.· Director· May 26, 2026
Neela Therapeutics, Inc. raised $12.0M
Neela Therapeutics, Inc.· Director· Nov 24, 2025
Asia Hedged Opportunity Fund, LLC raised $59.9M
Asia Hedged Opportunity Fund, LLC· Executive Officer· Mar 11, 2025
Newleos Therapeutics, Inc. raised $93.4M
Newleos Therapeutics, Inc.· Director· Feb 24, 2025
Newleos Therapeutics, Inc. raised $93.4M
Newleos Therapeutics, Inc.· Executive Officer· Feb 24, 2025
Atlas Point Global Multi-Strategy Offshore Fund Ltd. raised $35.2M
Atlas Point Global Multi-Strategy Offshore Fund Ltd.· Executive Officer· Feb 5, 2025
Alcyone Therapeutics, Inc. raised $19.0M
Alcyone Therapeutics, Inc.· Director· Jan 8, 2025